Am J Health Syst Pharm. 2011;68(10):879-886. The mean duration of patient follow-up was 21 months. The mean daily maintenance nebivolol dose was 7.7 mg, with 68% of nebivolol-treated patients ...
New York, NY -A new beta blocker, nebivolol (Bystolic, Forest/Mylan), has been approved by the US FDA for the treatment of hypertension. The drug is a selective beta 1 blocker and has the added ...
Carvedilol is a beta-blocker medication approved by the Food and Drug Administration (FDA) to treat chronic heart failure, left ventricular dysfunction (LVD) following a heart attack, and high blood ...
What is the best choice for cardioprotection in a woman aged 75 years with episodic symptomatic angina, MI one year earlier and a sensitivity to nitroglycerin patches (i.e., skin erythema, burning, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results